Global Pharmaceutical Sales Expected To Reach $880 billion in 2011
This article was originally published in The Pink Sheet Daily
Executive SummaryIMS Health says the pharmaceutical industry will do better in 2011 than it is doing this year, but a full rebound is not on the horizon, as generics and payor restrictions continue to take a toll.
You may also be interested in...
Cost Of Drug Treatment In Medicare's Top Therapeutic Areas Dropping Quickly With Generics, IMS Data Show
Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.